Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Shift4 Payments Industry Stock Comparison

Sell
28

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
17.71
Seasonality Move:
-8.08%
Buy
74

FOUR
Shift4 Payments

Last Price:
67.30
Seasonality Move:
-7.96%
Sell
28
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.94. The Score for BIS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Shift4 Payments (FOUR) is a Buy

Is Shift4 Payments a Buy, Sell or Hold?

  • The current Shift4 Payments [FOUR] share price is $67.28. The Score for FOUR is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • FOUR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOUR Stock Price Chart

What is Shift4 Payments's stock price today?

  • The Shift4 Payments share price today is $67.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOUR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 46.95 Sell
Chaikin Money Flow: 4787 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.4 - 18.96) Sell
Bollinger Bands (100): (17.21 - 19.11) Sell

FOUR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.82 Buy
Relative Strength Index (14 RSI): 54.08 Buy
Chaikin Money Flow: 799868 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.72 - 68.12) Buy
Bollinger Bands (100): (63.51 - 77.51) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.84 Buy
20-day SMA: 17.85 Buy
50-day SMA: 18.64 Sell
200-day SMA: 20.1 Sell
8-day EMA: 17.94 Sell
20-day EMA: 18.08 Sell
50-day EMA: 18.38 Sell
200-day EMA: 19.43 Sell

FOUR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.64 Buy
20-day SMA: 65.26 Buy
50-day SMA: 64.6 Buy
200-day SMA: 64.8 Buy
8-day EMA: 66.64 Buy
20-day EMA: 65.69 Buy
50-day EMA: 66.2 Buy
200-day EMA: 66.22 Buy

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Shift4 Payments Earnings Growth & FOUR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.10 per share, an increase this year of $0.77 per share, and an increase next year of $1.06 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Shift4 Payments Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):